More about

Nonalcoholic Fatty Liver Disease

News
March 15, 2021
1 min read
Save

Endoscopic bariatric treatments improve fibrosis in NAFLD

Endoscopic bariatric treatments improve fibrosis in NAFLD

Patients with non-alcoholic fatty liver disease who underwent endoscopic bariatric and metabolic therapies saw improvements in liver fibrosis and other outcomes, according to study results.

News
March 11, 2021
1 min read
Save

CPAP unlikely to improve nonalcoholic fatty liver disease in patients with sleep apnea

CPAP unlikely to improve nonalcoholic fatty liver disease in patients with sleep apnea

CPAP alone did not improve hepatic steatosis and fibrosis in patients with nonalcoholic fatty liver disease and obstructive sleep apnea, researchers reported in the American Journal of Respiratory and Critical Care Medicine.

News
March 09, 2021
1 min read
Save

NAFLD linked with increased risk for extrahepatic cancers

NAFLD linked with increased risk for extrahepatic cancers

Patients with non-alcoholic fatty liver disease had a moderately increased risk for extrahepatic cancers, such as gastrointestinal, breast and gynecological cancers, according to a meta-analysis.

News
March 03, 2021
1 min read
Save

Persistent passive smoking exposure increases NAFLD risk

Persistent passive smoking exposure increases NAFLD risk

Exposure to passive smoking from childhood through adulthood was associated with increased risk for non-alcoholic fatty liver disease, according to study results.

News
February 25, 2021
1 min read
Save

AGA: Lifestyle modifications ‘cornerstone’ to achieving weight loss in NAFLD

AGA: Lifestyle modifications ‘cornerstone’ to achieving weight loss in NAFLD

The AGA Institute Clinical Practice Updates Committee and the Governing Board published evidence-based intervention advice for lifestyle modifications for treating nonalcoholic fatty liver disease in Gastroenterology.

News
January 27, 2021
1 min read
Save

NAFLD linked with increased readmissions in IBD

Patients with inflammatory bowel disease who also had non-alcoholic fatty liver disease had higher readmission rates, according to research presented at Crohn’s and Colitis Congress.

News
January 15, 2021
11 min read
Save

The race is on for medical treatment of NASH

The race is on for medical treatment of NASH

Nonalcoholic steatohepatitis is the second leading indication for liver transplantation in the United States but there are currently no FDA-approved treatments available.

News
January 15, 2021
4 min read
Save

NASH: A pandemic with an unmet need for pharmacotherapies

NASH: A pandemic with an unmet need for pharmacotherapies

There is a significant medical need to find effective pharmacotherapies to manage NASH, the liver disease that is really a pandemic.

News
December 30, 2020
1 min read
Save

Ideal CV health behaviors tied to lower odds of NAFLD

Ideal CV health behaviors tied to lower odds of NAFLD

Ideal CV health behaviors were associated with lower nonalcoholic fatty liver disease, or NAFLD, prevalence among participants in the Multi-Ethnic Study of Atherosclerosis cohort.

News
December 28, 2020
2 min read
Save

Type 2 diabetes, moderate alcohol consumption increase advanced fibrosis risk in NAFLD

Type 2 diabetes, moderate alcohol consumption increase advanced fibrosis risk in NAFLD

Moderate alcohol consumption is associated with an increased risk for advanced fibrosis in nonalcoholic fatty liver disease, with the risk highest among those with type 2 diabetes, according to study data.

View more